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1. Introduction 
The term osteomyelitis encompasses a broad group of infectious diseases characterized by 
infection of the bone and/or bone marrow. The pathogenesis of these diseases can follow 
acute, subacute or chronic courses and involves a range of contributory host and pathogen 
factors. A commonly used aetiological classification distinguishes between three types of 
osteomyelitis: acute or chronic haematogenous disease seeded by organisms in the 
bloodstream, local spread from a contiguous source of infection and secondary osteomyelitis 
related to vascular insufficiency. 
1.1 Acute haematogenous osteomyelitis 
Acute haematogenous osteomyelitis refers to infection of bone resulting from bacteria in the 
bloodstream. This is seen most often in children, with initial infection thought to occur in the 
richly vascularised metaphyseal region (Gutierrez, 2005). Children are thought to experience 
frequent episodes of bacteraemia, often with no apparent symptoms, leading to seeding and 
development of osteomyelitis (Conrad, 2010). The pathogenesis of this process has been 
theoretically described. Inoculation of the metaphyseal vessels occurs at the transition point 
from the arteriolar vessels to the venous sinusoids, slowing blood flow and increasing 
vascular turbulence (Jansson et al., 2009). These sites of turbulence may be predisposed to 
bacterial infection by providing an opportunity for local invasion (Fig. 1). 
Although rarely seen in developed countries, haematogenous osteomyelitis may take on a 
chronic course within bone if left untreated. Sequelae of this devastating condition may 
include chronic sinuses with exposed bone, loss of structural integrity and growth 
disturbances (Beckles et al., 2010). 
Local trauma to bone in the setting of bacteraemia may also be a contributing factor. Animal 
studies have shown significantly increased rates of haematogenous osteomyelitis when 
direct injury to bone was combined with intravenous bacterial seeding. (Kabak et al., 1999; 
Morrissy & Haynes, 1989). A recent series of 450 cases of acute haematogenous osteomyelitis 
found the rate of preceding blunt trauma to be 63% (Labbe et al., 2010). Further research is 
needed to elucidate the role of trauma in this condition. 
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Fig. 1. Schematic drawing showing the vascular supply to the physis. The callout represents 
a detailed view of the physis. The red arrow indicates an area of transition. These 
transitional zones show increased turbulence and allow for local invasion. (Image used with 
permission from Dr. Kaye Wilkins) 
1.2 Vertebral osteomyelitis 
Osteomyelitis involving the spine is also most commonly caused by haematogenous seeding 
of bacteria into the vertebrae (Tay et al., 2002). The pathophysiology of this condition reflects 
the unique vascular structures of the spine. The venous anatomy of the spine, originally 
investigated for its role in cancer metastasis, allows retrograde flow from the pelvic venous 
plexus due a lack of valvular structures, providing an opportunity for haematogenous 
deposition of bacteria (Batson, 1967). Fine arteriolar structures surrounding the vertebral 
end plate may also represent a location at which bacteria can become trapped (Wiley & 
Trueta, 1959). Infections are predominantly localized to the lumbar and thoracic spine, with 
significantly less frequent involvement of the cervical spine (Beronius et al., 2001). In 
children, a markedly different disease process has been observed in infections of the spine. 
Blood vessels in the paediatric spine pass through the physeal cartilage and terminate 
within the intervertebral disc, allowing for seeding of infection from the osseous vasculature 
(Tay, et al., 2002). This results in a direct extension of infection into the disc that is not seen 
in adult patients (Fig. 2). For this reason, this condition is referred to by some authors as 
paediatric discitis rather than osteomyelitis. 
1.3 Osteomyelitis secondary to contiguous infection 
In adult patients, the majority of osteomyelitis cases are due to inoculation from contiguous 
infection. Sources can include direct contamination at a site of injury, iatrogenic 
contamination at the time of an invasive procedure, or invasive infection from surrounding 
soft tissue. The epidemiology of contiguous infection osteomyelitis is biphasic, with young 
patients suffering trauma and related surgery and older patients suffering decubitus ulcers 
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Fig. 2. MRI scan showing disc space infection. The lack of normal disc signal at the circled 
segment (black arrow) represents infection. This type of spinal infection is seen more 
commonly in children. (Image used with permission from Dr. Kaye Wilkins). 
(Mader et al., 1999). Chronic infection often results, with clinical courses complicated by loss 
of bone structural integrity and soft tissue envelope disturbance. 
The progression of disease in localized osteomyelitis is characterized by a cycle of microbial 
invasion, vascular disruption, necrosis and sequestration. The host inflammatory response, 
discussed in detail below, results in obstruction of small vessels due to coagulopathy and 
oedema. As a result of this, cortical bone undergoes necrosis and is detached from 
surrounding live bone, creating an area known as a sequestrum. This provides a fertile 
environment for further bacterial invasion and progression continues. Simultaneously, 
induction of bone begins at the intact periosteum, forming a layer of viable osseous tissue 
around the site of infection known as involucrum. This mechanism is thought to result from 
an inflammatory reaction of the periosteum. 
Osteomyelitis of the diabetic foot represents a common form of localized infection. 
Aetiological factors have been thought to include peripheral neuropathy with associated 
superficial ulceration and peripheral vascular disease. However, a large recent study of risk 
factors for osteomyelitis in 1666 diabetic patients found no association of osteomyelitis with 
either peripheral neuropathy or vascular disease (Lavery et al., 2009). History and physical 
examination findings associated with increased relative risk for osteomyelitis in this study 
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included a previous history of foot ulceration prior to enrolment, the presence of multiple 
foot wounds or wounds that penetrated deep to bone or joint. This supports prior literature 
suggesting that clinical ability to probe bone directly in a diabetic ulcer is diagnostic of 
underlying osteomyelitis (Grayson et al., 1995). 
2. Host factors 
The pathogenesis of osteomyelitis is a complex process involving interactions between a 
host and an infectious agent. The host’s inflammatory response to a pathogen can further 
the physical spread of disease by clearing space in bone. Predisposing genetic differences in 
immune function are increasingly seen as an aetiological factor in some cases of 
osteomyelitis.  Acquired factors such as diseases causing immune or vascular compromise 
and implantation of foreign materials are frequently involved in the disease process as well. 
2.1 Inflammatory response to infection 
The unique demarcated environment of osteomyelitis results in a high-grade local 
inflammatory host response with systemic effects ranging from minimal to severe. The 
initial host response to infection of bone is characterized by a local increase in 
proinflammatory cytokines. Involvement of human monocyte cells in this process has been 
well-described. When presented with Staphylococcus aureus cells or bacterial cell wall 
components such as peptidoglycan (PepG) or lipopolysaccharide (LPS), monocytes secrete 
large amounts of interleukin 1-beta (IL-1beta), IL-6, IL-8, tumour necrosis factor alpha (TNF-
alpha) and macrophage inflammatory protein 1-alpha (MIP-1alpha) (Fullilove et al., 2000; 
Klosterhalfen et al., 1996; Wang et al., 2000). This has been confirmed in an in vivo animal 
model demonstrating up-regulation of cytokines following intravenous infusion of PepG 
and LPS (Ruud et al., 2007). 
Matrix metalloproteases, a zinc-dependent group of endopeptidases, have been proposed as 
a key element of bone loss in osteomyelitis. These enzymes are secreted by mesenchymal 
stromal cells and osteoblasts and work to degrade the extracellular matrix (ECM) in various 
ways. MMPs have also been shown to activate osteoclast function, leading directly to cell-
mediated bone resorption (Ortega et al., 2003). Future therapeutic interventions may target 
these inflammatory pathways to influence progression of disease. 
2.2 Genetics 
The role of genetics in the pathogenesis of osteomyelitis is a field of growing research 
interest. This has partly been driven by new technologies that quickly and affordably 
perform DNA sequencing of targeted areas. Multiple genetic differences have been 
identified between patients with osteomyelitis and control subjects, indicating possible 
hereditary susceptibilities.  A recent study identified polymorphisms resulting in 
upregulation of MMPs with significantly higher frequency in patients with osteomyelitis 
than in healthy controls (Angel Hugo Montes et al., 2010).  The mutation may cause an 
increase in osteoblast MMP1 production, which has been linked to osteodestructive activity 
in metastasis (Lu et al., 2009) and inflammatory arthropathy (Neidhart et al., 2009).  The IL-
1α (-889 TT) genotype has also been found to be more common in patients with 
osteomyelitis. (VÃctor Asensi et al., 2003; Tsezou et al., 2008).  Mutations in the G(-248)A 
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Genetic change 
Related 
molecules 
Potential mechanism 
MMP1 (- 1607 
1G/2G) 
MMP1 
Increased osteoblast MMP1 production in 2G 
allele carriers  
IL-1α (-889 CC/TT) IL-1α  Increased IL-1α circulating levels in carriers of -
889 polymorphism (Hulkkonen et al., 2000) 
IL-4 (-1098 GG/TT 
and -590 CC/TT) 
IL-4 
Increased frequency in osteomyelitis patients; 
unknown mechanism  
IL-6 (-174 GG/CC) IL-6 
Increased frequency in osteomyelitis patients; 
unknown mechanism  
G(-248)A promoter Bax protein 
Lower neutrophil apoptosis rate and longer 
neutrophil life span in A allele carriers  
NOS3 (27-bp repeat, 
intron 4) 
endothelial NOS3 
synthase 
Increased NO production in the presence of 
bacteria (Victor Asensi et al., 2007) 
TLR4 (Asp299Gly) 
Toll-like receptor, 
NF-kappaB 
Decreased IL-6 and TNF-alpha levels; 
phosphorylation of NF-kappaB inhibitor in 
polymorphism carriers (A. H. Montes et al., 2006) 
HLA-DRB1*100101 
HLA class II 
alleles 
Increased susceptibility of HLA genotype carriers 
to sickle cell osteomyelitis (Al-Ola et al., 2008) 
Table 1. Selected genetic factors related to osteomyelitis 
polymorphism at the promoter region of the bax gene was observed significantly more 
frequently in osteomyelitis patients (Ocaña et al., 2007). 
2.3 Osteomyelitis secondary to host disease 
Patients with diseases of the immune system are at increased risk for osteomyelitis. For 
patients with human immunodeficiency virus (HIV) infection, musculoskeletal infection can 
represent a devastating complication. Mortality rates for osteomyelitis in HIV-infected 
patients of >20% have been reported, although published data involve patients treated prior 
to the use of highly active antiretroviral therapy (HAART) (Vassilopoulos et al., 1997). 
Future research addressing the outcomes of musculoskeletal infections in HIV-infected 
patients with modern treatment regimens is needed to provide a clearer picture of this 
disease process. 
The pathophysiology of osteomyelitis in the HIV-infected patient is multifactorial, with 
vascular disruption suggested as a contributing aetiological factor. In a small series taken 
from a single infectious disease practice in the United States, the incidence of avascular 
necrosis in an HIV-positive population has been reported to be 45 times that seen in the 
general population (Brown & Crane, 2001). This could play a role in initial bacterial 
colonization. Infections with S. aureus remain the most common type seen in HIV-positive 
patients. However, atypical infections with agents such as Mycobacterium tuberculosis or 
Bartonelle henselae are also frequently reported (Tehranzadeh et al., 2004).  
Other disease processes have also been associated with opportunistic infectious agents due 
to specific deficits in host function. Multiple cases of Aspergillus osteomyelitis have been 
reported in sufferers of chronic granulomatous disease (Dotis & Roilides, 2011). Fungal 
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invasion of bone is facilitated in these patients due to defective phagocyte function. In 
patients suffering from sickle cell disease, microvascular changes lead to predisposition for 
bone infection.  While authors disagree as to whether Salmonella or Staphlyococcus 
osteomyelitis represents the most common form of bone infection seen in the sickle cell 
population, published literature uniformly supports a higher rate of Salmonella 
osteomyelitis than in the general population (Hernigou et al., 2010; Smith, 1996). The 
pathogenesis of Salmonella osteomyelitis in sickle cell patients may be related to 
gastrointestinal mini-infarction and resultant bacteraemic episodes. Bone infarction due to 
impaired microcirculation and impaired opsonisation has also been suggested to play a role 
(Wilson & Thomas, 1979). Clinical understanding of predisposition and altered 
pathophysiology of osteomyelitis in patients with these underlying illnesses is required for 
prompt diagnosis and appropriate treatment. 
2.4 Implanted materials and osteomyelitis 
Surgically implanted devices in and around bone represent a risk factor for the development 
of osteomyelitis. Due to the high global rate of total hip and knee replacement, 
endoprostheses represent an increasingly common source of infection, although infections 
of other implants such as orthopaedic internal fixation devices are also commonly seen. 
Stainless steel, titanium, and titanium alloys are the most commonly used materials for 
osteosynthesis implants, although biodegradable polymers such as poly(L-lactide) are 
regularly used in non-load bearing fractures, eg, some areas of maxillofacial surgery. The 
differences between stainless steel and titanium are well documented (Arens et al., 1996; 
Melcher et al., 1994), with stainless steel implants being associated with significantly greater 
infection rates than titanium implants. A possible reason for this is the fact that soft tissue 
adheres firmly to titanium-implant surfaces (Gristina, 1987; Perren, 1991), whilst a known 
reaction to steel implants is the formation of a fibrous capsule, enclosing a liquid filled void 
(Gristina, 1987). Bacteria can spread and multiply freely in this unvascularized space, which 
is also less accessible to the host defence mechanisms. Electro-polishing titanium and 
titanium alloys has been shown to be more cytocompatible to fibroblasts in static culture 
conditions than standard surfaces (Meredith et al., 2005). Coatings based on human protein 
such as albumin or human serum have been shown to reduce S. aureus and S. epidermidis 
adhesion to the surface (Kinnari et al., 2005). Poly(l-lysine)-grafted-poly(ethylene glycol) 
(PLL- g-PEG) coatings have been extensively studied for use in biomedical applications, and 
are highly effective in reducing the adsorption of blood serum, blood plasma and single 
proteins, such as fibrinogen and albumin (Tosatti et al., 2003). It is also known that fibroblast 
and osteoblast cell adhesion and spreading on metal oxide surfaces coated with PLL-g-PEG 
is strongly reduced in comparison to uncoated oxide surfaces (VandeVondele et al., 
2003).There has also been interest in coating osteosynthesis implants (stainless steel, 
titanium, or titanium alloy) with a thin layer of antibiotic-loaded biocompatible, 
biodegradable polymer, such as polylactic-co-glycolic acid (PLGA) (Price et al., 1996), and 
poly(D,L-lactide) (PDLLA) (Gollwitzer et al., 2003). The ideology behind this is that the 
antibiotic is slowly eluted locally at high concentration from the polymer coating as it 
degrades. Various antibiotics have been studied, including gentamicin (Gollwitzer, et al., 
2003), ciprofloxacin (Makinen et al., 2005) and vancomycin (Adams et al., 2009). However, 
the main concern with all of these antibiotics is the development of bacterial resistance. To 
prevent this, the amount of antibiotic eluted from the implant must remain above the 
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minimal inhibitory concentration (MIC) value of the selected antibiotic for the time the 
implant is in the body. A novel idea to prevent bacterial colonization on external fixation 
devices and wires was described by Forster et al (Forster et al., 2004), who fitted gentamicin-
coated polyurethane sleeves over the pins and wires of the external fixation device. The 
sleeves substantially reduced the incidence of pin tract infections caused by S. epidermidis, 
and elution tests revealed that the concentration of gentamicin in the pin tract remained 
above the 4 μg/ml MIC breakpoint for gentamicin for up to 26 weeks. To date no surface 
modification or coating fully prevents bacterial adhesion, however, many of the methods 
discussed have decreased the numbers of adherent bacteria significantly. An important 
factor to help the fight against infection is the development of biocompatible surfaces or 
coatings that allow fibroblast and osteoblast cells to adhere and proliferate, leading to soft- 
and hard-tissue integration and vascularization, while preventing bacterial adhesion. This 
tissue-covered implant surface then confronts bacteria with an integrated viable tissue layer 
with a functional host defence mechanism, and may therefore be the best solution we have 
so far in conquering bacterial adhesion (Harris & Richards, 2006). 
The majority of these infections can be traced to intraoperative contamination rather than 
haematogenous spread (Gillespie, 1990). Because of this, absolute sterility of the operating 
theatre and implants must be ensured during implantation. The pathogenesis of implant-
related infections of bone is related to interactions between the device and local 
granulocytes, which impairs host clearance of microbes (Zimmerli & Sendi, 2011). Treatment 
of these infections is complicated by the propensity of infectious agents to form biofilms on 
implanted surfaces, as discussed in detail below. 
3. Pathogen factors 
The initial event in the localization of infection appears to be adhesion of the bacteria to the 
extracellular matrix (ECM). Various factors govern this adhesion process. Once a bacteria 
reaches the biomaterial surface by haematogenous route they acquire a conditioning film of 
ECM proteins. Osteoblast play an active role in the internalization of the bacteria. 
Subsequently a multi-layered biofilm is made by the bacteria, which protects it from 
phagoctytosis and antibiotics. 
3.1 Extracellular matrix attachment and adhesins 
The ECM is a biologically active layer composed of a complex mixture of macromolecules, 
such as fibronectin, fibrinogen, albumin, vitronectin, and collagen. Host cell adhesion, 
migration, proliferation, and differentiation are all influenced by the composition and 
structural organization of the surrounding ECM. Interaction between host cells and the 
ECM is known to be mediated by specific receptors such as integrins, which are composed 
of  and ß units and link many ECM proteins to the eukaryotic cellular cytoskeleton 
(Ruoslahti, 1991). The ECM not only serves as a substrate for host cells, but also for 
colonizing bacteria. If an infection is to develop, pathogenic bacteria must cling to the tissue 
in order to overcome removal by physical forces. As well as using non-specific hydrophobic 
and electrostatic forces to interact with their hosts, bacteria have surface proteins with 
specific affinity for components of the ECM and for plasma proteins. These proteins are 
often called ECM-binding proteins (ECMBPs) or MSCRAMMs (microbial surface 
components recognizing adhesive matrix molecules). The S. aureus proteins responsible for 
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binding to fibronectin (fibronectin binding protein; fnbp), collagen (collagen binding protein; 
cna) and fibrinogen (clumping factor; cifA and cifB) are the best-studied ECMBPs (Flock, 
1999). Peacock et al. showed that seven putative virulence genes in S. aureus, including the 
adhesin genes fnbA and cna, the toxin genes sej, eta and hlg, and icaA, which are involved 
in biofilm production, were found to be associated with invasive isolates (Peacock et al., 
2002). Some studies have shown that immunization with cna can protect against septic 
death (Nilsson et al., 1998; Smeltzer & Gillaspy, 2000). Smeltzer concluded in his study 
that the inclusion of immunogens derived from conserved adhesins (e.g., fnbpA and clfA) 
would be required to achieve maximum effectiveness. However, failure to include cna 
would result in an immune response that would not necessarily limit the ability of a cna-
positive strain to colonize musculoskeletal tissues (Smeltzer & Gillaspy, 2000). Besides 
collagen binding, S. aureus cells isolated from patients with osteomyelitis bind to bone 
sialoprotein suggesting that sialoprotein binding may also serve to localize the infection 
to bone tissue (Ryden et al., 1989). 
Capsular polysaccharides expressed on the bacterial cell surface are a major virulence factor 
known to promote evasion of or interference with the host immune system. Binding of S. 
aureus to bone collagen is clearly associated with the protein ‘adhesin’ and is inhibited by 
the presence of a capsule on the bacterium. The latter has been demonstrated by 
experiments utilizing S. aureus strains Cowan and Wood. Strain Cowan (originally isolated 
from a patient with septic arthritis) lacks a capsule and demonstrates extensive binding to 
purified type I collagen. Strain Wood is encapsulated and demonstrated very poor binding 
ability to purified type I collagen in the same study (Buxton et al., 1990). 
3.2 Attachment to biomaterial surfaces 
S. aureus is a common cause of metal-biomaterial, bone-joint, and soft-tissue infections (Petty 
et al., 1985), while S. epidermidis is more common with polymer-associated implant 
infections (von Eiff et al., 2002). It has been shown that both fibrinogen (Brokke et al., 1991) 
and fibronectin (Fischer et al., 1996) deposited in vivo onto the implant surface mediate 
bacterial adherence. Bacteria compete with host cells for attachment to the implant surface, a 
phenomenon that has been referred to as ‘the race for the surface’ (Gristina, 1987) (Fig. 3). 
Once a biomaterial has been implanted, they acquire a conditioning film of ECM proteins 
(Baier et al., 1984). 
3.3 Role of osteoblasts 
The skeleton is a dynamic organ system, in a state of perpetual turnover which is 
continually remodelled by the actions of two cell types (Henderson & Nair, 2003). 
Osteoblasts are responsible for the deposition of bone matrix; they are found on bone 
surfaces and are derived from mesenchymal osteoprogenitor cells. These cells secrete 
osteoid, a mixture of bone matrix proteins primarily made up of type I collagen (over 90%), 
proteoglycans such as decorin and biglycan, glycoproteins such as fibronectin, osteonectin 
and tenascin-C, osteopontin, osteocalcin and bone sialoprotein, oriented along stress lines 
(Mackie, 2003).The opposing action of bone matrix removal is performed by osteoclasts, 
multinucleate cells that are derived from the macrophage-monocyte lineage. These cells 
express large quantities of a vacuolar-type H(+)-ATPase on their cell surface, along with 
chloride channel 7 (ClC 7) enabling localized hydrochloric acid secretion into a closed  
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Fig. 3. Adherence of contaminating bacteria to implant surfaces competes with attachment of 
host cells. The implant surface soon becomes covered with plasma proteins, mainly fibrinogen, 
to which both host cells and bacteria can bind. In this ‘race for the surface’, bacteria are often 
the winners. Secondary to adherence to fibrinogen, staphylococci (mainly S. epidermidis) 
produce slime, further promoting adherence. Early intervention by blocking primary bacterial 
adherence would favour eukaryotic cells in the race. The slimy polysaccharide prevents 
phagocytosis and protects the bacteria from antibiotics. Reprinted from Flock, J.I., Extracellular-
matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections. Mol Med 
Today, 1999. 5(12): p. 532-7 with permission from Elsevier. 
compartment, known as the resorption lacuna, and subsequent solubilization of bone 
mineral (Blair et al., 1989). The balance of activity between these two cell types is crucial to 
maintaining the proper homeostasis of bone turnover, and any shift in the relative levels of 
osteoblast and osteoclast activity can result in bone pathology (Henderson & Nair, 2003). 
Infection with a pathogen such as S. aureus is capable of stimulating such a shift, mediated 
in part by induction of an inflammatory response. There is an intimate interaction between 
the two cell types, with osteoblasts interpreting the majority of extracellular signals and 
subsequently modulating osteoclast differentiation and function (Henderson & Nair, 2003; 
Matsuo & Irie, 2008). Interaction between the RANK (receptor activator for nuclear factor 
κB) receptor, expressed by osteoclast precursors, and its cognate ligand, RANKL, expressed 
by osteoblasts is essential for osteoclastogenesis (Matsuo & Irie, 2008). Osteoprotegrin (OPG) 
is an endogenous inhibitor of RANKL signaling, functioning as a decoy receptor that binds 
to RANKL and prevents its association with RANK (Wada et al., 2006). 
S. aureus permanently colonizes the anterior nares of the nostrils of about 20% of the 
population and is transiently associated with the rest (Foster, 2009). Colonisation is a risk 
factor for developing infection. Until recently S. aureus was regarded as an extracellular 
pathogen. However it is clear that the organism can adhere to and become internalized by a 
variety of host cells (Garzoni & Kelley, 2009), including osteoblasts (Ahmed et al., 2001), and 
that this is likely to be important in disease pathogenesis. S. aureus expresses several 
components that are capable of interacting with osteoblasts. Hudson demonstrated initial 
association of S. aureus strains with osteoblasts was independent of the presence of matrix 
collagen produced by the osteoblasts (Hudson et al., 1995). Internalization of bacteria 
required live osteoblasts, but not live S. aureus, indicating osteoblasts are active in ingesting 
the organisms. The bacteria were not killed by the osteoblasts, since viable bacteria were 
cultured several hours after ingestion. From a clinical standpoint, it has become clear that 
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patients can have recurrent attacks of osteomyelitis after completion of therapy even when 
causative organisms cannot be isolated (Craigen et al., 1992). The observation that S. aureus 
can be internalized by osteoblasts may be relevant to this clinical problem. 
Uptake is promoted by fibronectin binding proteins that capture fibronectin and use it as a 
bridge between bacteria and the a5b1 integrin (Sinha et al., 1999). Integrin clustering results 
in signaling that leads to bacterial uptake into phagocytic vesicles. The mechanism of 
invasion differs between S. aureus and S. epidermidis and the latter does not gain entry via 
the fibronectin-integrin α5β1 mechanism (Khalil et al., 2007). The level of expression of the 
alternative sigma factor, σB, affects fnbA expression and the fibronectin binding ability of S. 
aureus strains correlates with the level of internalization of bacteria by osteoblasts suggesting 
that σB-mediated up-regulation of FnBP expression may facilitate invasion (Nair et al., 
2003). Once internalized bacteria can escape the phagosome and cause necrosis (Wright & 
Nair, 2010). Slow growing variants (called small colony variants) often emerge allowing the 
bacteria and the infection to persist (von Eiff, Bettin et al., 1997). These bacteria are mutant 
forms of Staphylococcus that may have an adaptive advantage enabling persistent bone 
colonisation. Small colony variants can be associated with both refractory and relapsing 
infections that are poorly responsive to standard treatment regimens. Their decreased 
metabolic activity and decreased a-toxin production may enable them to survive 
intracellularly and to exhibit decreased susceptibility to antibiotics (von Eiff, Heilmann et 
al., 1997). Because of their slow growth, atypical colonial morphology, and other altered 
phenotypes, these organisms may be missed or incorrectly identified by clinical laboratories 
(Proctor et al., 1995). 
Protein A (SpA) is an important virulence factor of S. aureus. It binds to a variety of ligands 
including the Fc region of IgG (Cedergren et al., 1993), Willebrand factor (O'Seaghdha et al., 
2006), tumour necrosis factor receptor-1 (TNFR-1) (Gomez et al., 2006), the Fab-heavy chains 
of the Vh3 subclass (Viau & Zouali, 2005) and the epidermal growth factor receptor (EGFR) 
(Gomez et al., 2007). By binding the Fc portion of SpA ligand TNFa has been implicated in a 
wide spectrum of bone diseases including osteoporosis and rheumatoid arthritis (Chen & 
Goeddel, 2002). Several reports have demonstrated that S. aureus can induce apoptosis in 
osteoblasts (Alexander et al., 2003). Osteoblasts express high levels of TNFR-1. S. aureus SpA 
binds to osteoblasts, possibly through an interaction with the death receptor TNFR-1 which 
induces host cell expression of tumour necrosis factor apoptosis inducing ligand (TRAIL) 
produced by S. aureus-infected osteoblasts induces caspase-8 activation and apoptosis in 
cultured osteoblasts (Alexander, et al., 2003) (Fig. 4).  
TRAIL can induce apoptosis in human osteoclasts via TRAIL receptor 2, and also inhibits 
osteoclast differentiation (Colucci et al., 2007). It is therefore possible that apoptosis of bone 
cells infected with S. aureus, and potentially of neighbouring uninfected cells may contribute to 
bone loss in osteomyelitis (Henderson and Nair, 2003). S. aureus infection of osteoblasts led to a 
significant increase in RANKL expression in their membrane (Somayaji et al., 2008). RANKL 
displayed on the membrane of osteoblasts stimulates differentiation in osteoclasts and is a key 
induction molecule involved in bone resorption leading to bone destruction (Boyce & Xing, 
2008). In essence binding of major S. aureus virulence protein, SpA with osteoblasts results in 
the generation of multiple signals leading to inhibition of osteoblast proliferation, induction of 
osteoblast apoptosis, inhibition of mineralization and release of mediators capable of inducing 
bone resorption via osteoclast activation (Claro et al., 2011)(Fig. 4). 
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Fig. 4. Proposed mechanism of Staphylococcus aureus – osteoblast interaction. Claro, T., et al., 
Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in 
osteomyelitis. PLoS One, 2011. 6(4): p. e18748 
3.4 Biofilm formation 
A biofilm is defined as a microbially derived sessile community, typified by cells that are 
attached to a substratum, interface, or to each other, are embedded in a matrix of 
extracellular polymeric substance, and exhibit an altered phenotype with regard to growth, 
gene expression, and protein production (Donlan & Costerton, 2002). Biofilm depth can 
vary, from a single cell layer to a thick community of cells surrounded by a thick polymeric 
milieu. Structural analyses have shown that these thick biofilms possess a complex 
architecture in which microcolonies can exist in distinct pillar or mushroom-shaped 
structures (Costerton et al., 1995), through which an intricate channel network runs. These 
channels provide access to environmental nutrients even in the deepest areas of the biofilm. 
By adopting this sessile mode of life, biofilm-embedded microorganisms benefit from a 
number of advantages over their planktonic counterparts: 
1. The capability of the extracellular matrix to seize and concentrate a number of 
environmental nutrients, such as carbon, nitrogen, and phosphate (Beveridge et al., 1997).  
2. The facilitation of resistance to a number of removal tactics, such as elimination by 
antimicrobial agents, shear stress, host phagocytic clearance, and host oxygen radical 
and protease defences. This innate resistance to antimicrobial factors is mediated 
through very low metabolic levels and radically down-regulated rates of cell division of 
the deeply entrenched micro-organisms. 
3. The potential for dispersion via detachment. Microcolonies may detach under the 
direction of mechanical fluid shear or through a genetically programmed response that 
mediates the detachment process (Boyd & Chakrabarty, 1994). Under the direction of 
fluid flow, this microcolony travels to other regions of the host system to attach and 
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promote biofilm formation in previously uninfected areas. In addition, detachment and 
seeding of virgin surfaces may be accomplished by the migration of single, motile cells 
from the cores of attached microcolonies (Sauer et al., 2002). Therefore, this advantage 
allows an enduring bacterial source population that is resilient against antimicrobial 
agents and the host immune response, while simultaneously enabling continuous 
shedding to encourage bacterial spread. 
Formation of biofilm is a two-stage process in which bacteria first attach to a substrate (e.g., 
bone) and then attach to each other as the biofilm grows and matures. The two-stage process 
is consistent with the scenario described for S. epidermidis, which is a common cause of 
infections involving in-dwelling medical devices. In this case, the initial attachment appears 
to be dependent on the production of one or more protein adhesins, whereas the subsequent 
aggregation of bacteria into a biofilm is dependent on the production of exopolysaccharide 
adhesins (Heilmann et al., 1996). It is known that once a biofilm has formed, the bacteria 
within the biofilm are protected from phagocytosis and antibiotics (Hoyle & Costerton, 
1991), and a mouse bacteraemia model found that the biofilm enhanced S. aureus virulence 
factors, such as the α-toxin (Caiazza & O'Toole, 2003; Thakker et al., 1998). A final 
detachment (or dispersal) phase involves the detachment of single cells or cell clusters by 
various mechanisms and is believed to be crucial for the dissemination of the bacteria, in the 
case of pathogens to new infection sites in the human body. 
Staphylococcus spp. can produce a multilayered biofilm embedded within a glycocalyx, or 
slime layer. The glycocalyx develops on devitalized tissue and bone, or on medically 
implanted devices, to produce an infection (Akiyama et al., 1993). Early studies described 
the solid component of the glycocalyx as primarily composed of teichoic acids (80%) and 
staphylococcal and host proteins (Hussain et al., 1993). In recent years, the polysaccharide 
intercellular adhesin (PIA) has been found in many S. aureus strains (Cramton et al., 1999), 
and is required for biofilm formation and bacterium-bacterium adhesion (Fig. 6). PIA is 
produced in vitro from UDP-N-acetylglucosamine via products of the intercellular adhesion 
(ica) locus (Cramton, et al., 1999). The genes and products of the ica locus [icaR (regulatory) 
and icaADBC (biosynthetic) genes] have been demonstrated to be necessary for biofilm 
formation and virulence, and are up-regulated in response to anaerobic growth, such as the 
conditions seen in the biofilm environment (Cramton et al., 2001). Another important 
component of the staphylococcal biofilm is extracellular DNA (eDNA). The discovery that 
this substance is an important component of biofilms was recently made in P. aeruginosa 
(Whitchurch et al., 2002). Rice et al. very recently showed that eDNA is important for 
biofilm formation and adherence in S. aureus, and that this DNA release seems to be, at least 
in part, mediated through the cidA murein hydrolase (Rice et al., 2007). This gene has been 
shown to be a holin homologue involved in cell lysis, and it is thought that this gene allows 
S. aureus biofilm cells to lyse and release DNA into the extracellular milieu. 
Many factors seem to play a role in regulation of biofilm. The agr quorum sensing (QS) 
system, a central regulator of virulence, has been shown to down-regulate genes of cell wall-
associated adherence factors (Chan et al., 2004). This would lead to lesser adherence and 
thus, indirectly, decreased initial biofilm formation. As well, the agr system has been shown 
to up-regulate the expression of detergent-like peptides that seem to increase biofilm 
detachment (Kong et al., 2006), and mutation of the system leads to increased biofilm 
growth. Another regulatory system, Target of RAP (TRAP), has been implicated in biofilm 
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Fig. 5. SEM of a staphylococcal biofilm. Note the multiple layer of bacteria covered with a 
polysaccharide matrix. Reprinted from Cramton, S.E., et al., The intercellular adhesion (ica) 
locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun, 1999. 
67(10): p. 5427-33 with permission from Elsevier. 
formation, with its secreted factor [RNAIII activating peptide (RAP)] increasing biofilm 
growth and its antagonistic peptide [RNAIII inhibitory peptide (RIP)] inhibiting it (Korem et 
al., 2005). TRAP is believed to work through the Agr system, activating RNAIII production 
(the effector of the Agr response) when RAP levels are high (Balaban et al., 2007). 
Biofilms are recalcitrant to clearance by antimicrobials because of their altered metabolic and 
lessened diffusion of the antibiotic into the biofilm. Some of the recent strategies suggested are 
anti-PIA antibodies and use of RIP heptapeptide, which is proposed to inhibit RNAIII-
activated virulence factors (Giacometti et al., 2003; Maira-Litran et al., 2005; McKenney et al., 
1999). Surgical interventions remain the most effective means of treatment of biofilm-
associated infections. In osteomyelitis infections, this means debridement of all infected bone. 
4. Aetiology of osteomyelitis 
The spectrum of agents associated with osteomyelitis is an ever-widening one, partly 
because of accumulating evidence to suggest that microorganisms previously considered as 
specimen contaminants are capable of causing infection (Haidar et al., 2010; Wong et al., 
2010) and partly because of the increasing application of newer diagnostic modalities, such 
as DNA amplification. These methodologies are more sensitive than conventional 
microbiological techniques in identifying conventional, emerging and new pathogens in 
clinical material (Bang et al., 2008; Ceroni et al., 2010; Cremniter et al., 2008). Although 
Staphylococcus aureus remains the pre-eminent cause of infection, the wide and increasing 
range of aetiological agents associated with osteomyelitis presents a challenge to the 
clinician in terms of selection of empiric antimicrobial therapy; nevertheless particular 
clinical features as well as patient-specific risk factors and underlying conditions can be 
used to guide treatment. 
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As noted above, osteomyelitis can be broadly classified according to source of infection: 
spread from a contiguous site or following haematogenous seeding. The latter is more likely 
to be associated with monomicrobial infection while the former is often polymicrobial in 
origin including obligately anaerobic bacteria Osteomyelitis in individuals with vascular 
insufficiency including patients with diabetes mellitus is also frequently polymicrobial 
(Powlson & Coll, 2010). 
There are also aetiological associations with patient age. In neonates, for example, the 
bacteria most frequently associated with acute haematogenous osteomyelitis are those 
which cause neonatal sepsis, notably Lancefield group B streptococci (Streptococcus 
agalactiae) and Escherichia coli as well as S. aureus (Dessi et al., 2008). In older children, S. 
aureus infection predominates and in some countries, such as the US, community-acquired 
methicillin-resistant strains (CA-MRSA) are increasingly recognized (Vander Have et al., 
2009). Kingella kingae has also emerged in recent years as an important cause of osteomyelitis 
in children (Dubnov-Raz et al., 2008). In contrast, Haemophilus influenzae infections, once 
common in patients aged under five years, have markedly declined as a result of vaccination 
against Pittman type b strains of this bacterium (Howard et al., 1999).  In adults, as with 
younger patients, S. aureus is the most frequent agent of infection. 
 
Risk factor/feature Microorganism 
Geographic location 
Mycobacterium tuberculosis 
Brucella  species (Colmenero et al., 2008) 
Dimorphic fungi e.g. Coccidiodes immitis (Holley et al., 2002) 
Intravenous drug use 
Staphylococcus aureus 
Pseudomonas aeruginosa (Miskew et al., 1983) Candida albicans 
(Lafont et al., 1994) 
Eikenella corrodens ( “needle lickers’ osteomyelitis”) (Swisher 
et al., 1994) 
Post-human or animal bite 
Staphylococcus aureus 
Pasteurella multocida (Jarvis et al., 1981) 
Eikenella corrodens (Schmidt & Heckman, 1983) Obligate 
anaerobes (Brook, 2008) 
Vertebral osteomyelitis 
Staphylococcus aureus 
Coagulase-negative staphylococci 
Propionibacterium acnes (post-spinal surgery) (Kowalski, 
Berbari, Huddleston, Steckelberg, Mandrekar et al., 2007; 
Kowalski, Berbari, Huddleston, Steckelberg, & Osmon, 2007) 
Escherichia coli (McHenry et al., 2002) 
Pseudomonas aeruginosa (Patzakis et al., 1991) 
Prosthetic devices 
Staphylococcus aureus 
Coagulase-negative staphylococci 
Propionibacterium acnes (Lew & Waldvogel, 2004) 
Puncture wounds of the foot 
Pseudomonas aeruginosa (“sneaker osteomyelitis”) (Dixon & 
Sydnor, 1993) 
Table 2. Aetiological association 
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Osteomyelitis in patients with immunocompromise, both congenital and acquired, can be 
caused by an extremely wide range of conventional and opportunistic pathogens including 
fungi (See section 2.3). Examples of other aetiological associations are shown in Table 2. 
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